Timing of Surgery in Asymptomatic Mitral Regurgitation
- 3 March 2005
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 352 (9) , 928-929
- https://doi.org/10.1056/nejme048334
Abstract
The use of an evidence-based approach to the treatment of valvular heart disease has been hampered by the lack of rigorous data on predictors of the clinical outcome. The timing of surgery in patients with asymptomatic mitral regurgitation has been especially controversial for two reasons: the various causes of valve dysfunction and the lack of a precise measure of disease severity.1 Clinical outcomes and approaches to treatment depend on the cause of valve dysfunction. For example, in patients with secondary mitral regurgitation owing to dilated cardiomyopathy or ischemic disease, the prognosis depends mainly on the underlying disease and valve surgery . . .Keywords
This publication has 8 references indexed in Scilit:
- Quantitative Determinants of the Outcome of Asymptomatic Mitral RegurgitationNew England Journal of Medicine, 2005
- Dynamic Mitral Regurgitation — More Than Meets the EyeNew England Journal of Medicine, 2004
- Update on Mitral Repair in Dilated CardiomyopathyJournal of Cardiac Surgery, 2004
- Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiographyJournal of the American Society of Echocardiography, 2003
- Timing of surgery in mitral regurgitationHeart, 2003
- Evaluation and Management of Chronic Mitral RegurgitationNew England Journal of Medicine, 2001
- Functional anatomy of mitral regurgitationJournal of the American College of Cardiology, 1999
- ACC/AHA guidelines for the management of patients with valvular heart diseaseJournal of the American College of Cardiology, 1998